Abstract:BACKGROUND: Cardiac CD206+ macrophages expand acutely after myocardial infarction (MI) to promote wound healing; however, their role in chronic heart failure (HF) is unknown. We tested the hypothesis that cardiac CD206+ macrophages expressing interleukin(IL)-4Ralpha are key drivers of adverse left ventricular (LV) remodeling in HF. METHODS AND RESULTS: Adult male C57BL/6 mice underwent non-reperfused MI to induce HF, or sham operation, and cardiac macrophages were profiled using flow cytometry. As compared to sham, CD206+ macrophages steadily expanded in post-MI hearts during LV remodeling, such that at 8 w post-MI they comprised ~85% of all macrophages. These macrophages were robustly proliferative and predominantly C-C motif chemokine receptor (CCR2)− and major histocompatibility complex (MHC)IIhi, with >90% of CD206+CCR2− macrophages expressing the resident macrophage marker LYVE-1. CD206+ macrophage abundance correlated with LV dysfunction and fibrosis. Nearly half of CD206+ macrophages expressed IL-4Ralpha, and the majority of CD206+IL-4Ralpha+ macrophages co-expressed the pro-fibrotic protein found in inflammatory zone (FIZZ)1. IL-4-polarized bone marrow derived CD206+ macrophages also exhibited marked upregulation of FIZZ1 and induced FIZZ1-dependent myofibroblast differentiation of cardiac mesenchymal stem cells (cMSCs), in part related to DLL-4/Jagged1-Notch1 signaling. Intramyocardial adoptive transfer of M[IL-4], but not M[IL-10], CD206+ macrophages to naive mice, induced progressive LV remodeling over 4 weeks, increasing fibrosis, cardiomyocyte hypertrophy, and apoptosis. Myeloid-specific IL-4Ralpha gene deletion in established HF (initiated 4 w post-MI) in IL-4Ralphaf/fLysM-CreERT2 mice significantly reduced CD206+ macrophage proliferation and effectively depleted CD206+IL-4Ralpha+ cardiac macrophages. This was associated with abrogation of LV remodeling progression, reduction of cardiac fibrosis, and improved neovascularization. In vivo IL-4Ralpha gene silencing in mice with established HF effectively depleted cardiac CD206+IL-4Ralpha+ macrophages and reversed LV remodeling, improving fibrosis, neovascularization, and dysfunction, and suppressed both local and systemic inflammation. Lastly, alternatively activated CD206+ and CD163+ macrophages were significantly expanded in human failing hearts and correlated with fibrosis. The majority of CD163+ macrophages expressed IL-4Ralpha and FIZZ3, the human homolog of FIZZ1. CONCLUSION: Cardiac CD206+IL-4Ralpha+ macrophages proliferate and expand in HF and are key mediators of pathological remodeling and fibrosis, in part through the secretion of FIZZ1. Inhibition of CD206+ macrophage IL-4Ralpha signaling alleviates LV remodeling in ischemic cardiomyopathy.

Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

The Roles of Macrophages in Heart Regeneration and Repair after Injury

Distinct Origins and Functions of Cardiac Orthotopic Macrophages

Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction

The Evolving Roles of Cardiac Macrophages in Homeostasis, Regeneration, and Repair

Macrophage-driven Cardiac Inflammation and Healing: Insights from Homeostasis and Myocardial Infarction

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

Cardiac resident macrophages: The core of cardiac immune homeostasis

The role of cardiac resident macrophage in cardiac aging

Transcriptional regulation of macrophages in heart failure

Macrophages in cardiac homeostasis, injury responses and progenitor cell mobilisation

Macrophage Polarization in Cardiac Tissue Repair Following Myocardial Infarction

Macrophages after myocardial infarction: Mechanisms for repairing and potential as therapeutic approaches

Inflammation Macrophages Contribute to Cardiac Homeostasis

Resident macrophages as potential therapeutic targets for cardiac ageing and injury

Dissecting and Visualizing the Functional Diversity of Cardiac Macrophages

Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis

At the heart of inflammation: Unravelling cardiac resident macrophage biology

CD206+IL-4Ralpha+ MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY